In a national registry study of 90 children/adolescents with CML-CP, pathogenic somatic variants were detected in 16%, with ASXL1 the most frequent; carriers showed trends toward delayed cytogenetic/molecular responses [44]. The gene discussed is ASXL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.